CCO commentary from Steven L. Flamm, MD, on the importance of screening patients with chronic HBV infection for hepatocellular carcinoma
Hear CCO faculty Philip Newsome discuss the agents in late-phase clinical trials and their potential use in treatment of NASH and fibrosis
CCO faculty Dr Juan Frias discusses the agents in late-phase clinical trials and their potential use in treatment of NASH and fibrosis
Juan Frias and Philip Newsome: Learn about the agents in phase II and III clinical trials and their potential use in treatment.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.